AU2001265995A1 - Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists - Google Patents

Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists

Info

Publication number
AU2001265995A1
AU2001265995A1 AU2001265995A AU6599501A AU2001265995A1 AU 2001265995 A1 AU2001265995 A1 AU 2001265995A1 AU 2001265995 A AU2001265995 A AU 2001265995A AU 6599501 A AU6599501 A AU 6599501A AU 2001265995 A1 AU2001265995 A1 AU 2001265995A1
Authority
AU
Australia
Prior art keywords
carbamides
production
receptor antagonists
endothelin receptor
novel carbamates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001265995A
Inventor
Wilhelm Amberg
Georg Kettschau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
B A S F A G
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B A S F A G, BASF SE filed Critical B A S F A G
Publication of AU2001265995A1 publication Critical patent/AU2001265995A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001265995A 2000-05-25 2001-05-18 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists Abandoned AU2001265995A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10025728 2000-05-25
DE10025728A DE10025728A1 (en) 2000-05-25 2000-05-25 New carbamates and ureas, their production and use as endothelin receptor antagonists
PCT/EP2001/005742 WO2001090079A2 (en) 2000-05-25 2001-05-18 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists

Publications (1)

Publication Number Publication Date
AU2001265995A1 true AU2001265995A1 (en) 2001-12-03

Family

ID=7643406

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001265995A Abandoned AU2001265995A1 (en) 2000-05-25 2001-05-18 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists

Country Status (8)

Country Link
US (1) US20040034076A1 (en)
EP (1) EP1286973A2 (en)
JP (1) JP2003534329A (en)
AU (1) AU2001265995A1 (en)
CA (1) CA2410304A1 (en)
DE (1) DE10025728A1 (en)
MX (1) MXPA02011512A (en)
WO (1) WO2001090079A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790770B2 (en) 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4329911A1 (en) * 1993-09-04 1995-03-09 Basf Ag Substituted lactic acid derivatives with an N-organic radical in the beta position
DE19614534A1 (en) * 1996-04-12 1997-10-16 Basf Ag New carboxylic acid derivatives, their production and use
WO1999023078A2 (en) * 1997-10-31 1999-05-14 Basf Aktiengesellschaft Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists

Also Published As

Publication number Publication date
MXPA02011512A (en) 2003-06-30
WO2001090079A3 (en) 2002-04-04
WO2001090079A2 (en) 2001-11-29
DE10025728A1 (en) 2001-11-29
EP1286973A2 (en) 2003-03-05
US20040034076A1 (en) 2004-02-19
CA2410304A1 (en) 2002-11-22
JP2003534329A (en) 2003-11-18

Similar Documents

Publication Publication Date Title
HK1073070A1 (en) Novel biomaterials, their preparation and use
IL155805A0 (en) Novel sulfamides and their use as endothelin receptor antagonists
AU2001287574A1 (en) Human g protein-coupled receptor igpcr20, and uses thereof
PL347500A1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
PL347885A1 (en) Azepinoindole derivatives, the production and use thereof
AU2003265853A1 (en) Hedgehog antagonists, methods and uses related thereto
AU1378500A (en) Novel pyrimidines, the production thereof and their use
EP1233956A4 (en) Bryostatin analogues, synthetic methods and uses
AU2001269876A1 (en) Heteroarylalkanoic acids as integrin receptor antagonists
IL153789A0 (en) Chemokine receptor modulators, production and use
AU2001265862A1 (en) Graft copolymers based on polyurethane, the production thereof and their use
SI1268522T1 (en) Novel lhrh-antagonists, production and use thereof as medicament
AU2001290772A1 (en) Alpha v integrin receptor antagonists
AU6990000A (en) Novel integrin receptor antagonists
AU2298200A (en) Stabilized filler, its production and use
HUP0204389A3 (en) Perfluoroisopropylbenzene derivatives, use ful as intermediates and raw materials
HUP0302208A3 (en) Deltamethrin-containing, water-dispersible granular material, production and use thereof
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament
IL133104A0 (en) New - beta-amino and beta-azidocarboxylic acid derivatives the production thereof and the use thereof as endothelin receptor antagonists
AU2002368487A1 (en) Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists
AU2001265995A1 (en) Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
AU2003234975A1 (en) Natural anti-bacterial material and its use, anti-bacterial production
AU2001252046A1 (en) New bacteriocin, production and use thereof
AU2003223992A1 (en) Solid stabilizer composition, the production and the use thereof
AU2002331114A1 (en) Tetrahydroisochinolines, their production and the use thereof as analgesics